During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
Bob and Mike Bryan said they were withdrawing from the Games over concerns for their families health.
The former boss of BHS said a parliamentary committee that investigated the closure of the stores was a 'kangaroo court'.
Those going out tonight might need an extra layer as it will be noticeably chilly.